(Q45738176)

15 December 2017

Immunoprophylactic strategies against respiratory influenza virus infection (English)

1 reference

15 December 2017

Saravolac EG

1

1 reference

15 December 2017

Sabuda D

2

1 reference

15 December 2017

Crist C

3

1 reference

15 December 2017

Blasetti K

4

1 reference

15 December 2017

Schnell G

5

1 reference

15 December 2017

Yang H

6

1 reference

15 December 2017

Kende M

7

1 reference

15 December 2017

Levy HB

8

1 reference

15 December 2017

Wong JP

9

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

15 December 2017

1 reference

15 December 2017

19

1 reference

15 December 2017

17-19

1 reference

15 December 2017

2227-2232

1 reference

Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance

15 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900450-3

7 January 2021

Protection of mice from lethal influenza by adoptive transfer of non-neutralizing haemagglutination-inhibiting IgG obtained from the lungs of infected animals treated with defective interfering virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900450-3

7 January 2021

Protection against murine cytomegalovirus infection by passive transfer of neutralizing and non-neutralizing monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900450-3

7 January 2021

Intranasal interferon-alpha 2b for seasonal prophylaxis of respiratory infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900450-3

7 January 2021

Treatment with recombinant alpha-interferon of chronic hepatitis C in anti-HIV-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900450-3

7 January 2021

Clinical toxicity of interferons in cancer patients: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900450-3

7 January 2021

Clearance of phosphatidylcholine and cholesterol from liposomes, liposomes loaded with metaproterenol, and rabbit surfactant from adult rabbit lungs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900450-3

7 January 2021

Comparative Therapeutic Efficacy of Recombinant Interferons-α, -β, and -γ Against Alphatogavirus, Bunyavirus, Flavivirus, and Herpesvirus Infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900450-3

7 January 2021

The determination of an immunologically active dose of interferon-gamma in patients with melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900450-3

7 January 2021

Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900450-3

7 January 2021

A toxicity study of recombinant interferon-gamma given by intravenous infusion to patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900450-3

7 January 2021

Effect of liposome-encapsulation on immunomodulating and antiviral activities of interferon-gamma 1

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900450-3

7 January 2021

Enhanced efficacy of liposome-encapsulated ribavirin against Rift Valley fever virus infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900450-3

7 January 2021

A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900450-3

7 January 2021

Effect of a Nuclease-Resistant Derivative of PolyriboinosinicPolyribocytidylic Acid Complex on Yellow Fever in Rhesus Monkeys (Macaca mulatta)

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900450-3

7 January 2021

Successful Prophylaxis against Rabies in Mice and Rhesus Monkeys: The Interferon System and Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900450-3

7 January 2021

Protective and Toxic Effects of a Nuclease-Resistant Derivative of Polyriboinosinic.Polyribocytidylic Acid on Venezuelan Equine Encephalomyelitis Virus in Rhesus Monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900450-3

7 January 2021

Prophylactic and therapeutic efficacies of poly(IC.LC) against respiratory influenza A virus infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900450-3

7 January 2021

Phase I-II Trials of Poly(ICLC) in Malignant Brain Tumor Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900450-3

7 January 2021

Treatment of advanced ovarian cancer with polyinosinic-polycytidylic lysine carboxymethylcellulose (poly(ICLC))

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900450-3

7 January 2021

Liposome-mediated immunotherapy against respiratory influenza virus infection using double-stranded RNA poly ICLC.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900450-3

7 January 2021

10.1016/S0264-410X(00)00450-3

Identifiers

DOI

1 reference

15 December 2017

1 reference